Filing Details

Accession Number:
0001104659-20-131769
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-03 06:06:40
Reporting Period:
2020-12-01
Accepted Time:
2020-12-03 06:06:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1824893 Consonance-Hfw Acquisition Corp. CHFW Blank Checks (6770) 981556622
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1828234 Harold Kevin Livingston C/O Consonance-Hfw Acquisition Corp.
1 Palmer Square, Suite 305
Princeton NJ 08540
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Ordinary Shares Acquisiton 2020-12-01 24,000 $0.00 434,000 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Ordinary Shares Warrant Acquisiton 2020-12-01 8,000 $0.00 8,000 $11.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
144,667 No 4 P Indirect
Footnotes
  1. Includes securities underlying the 24,000 private placement units of the Issuer purchased by Consonance Life Sciences (the "Sponsor") for $10.00 per private placement unit. The private placement units were purchased in a private placement upon the exercise in full of the over-allotment option granted to the underwriters to purchase additional shares in the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share.
  2. The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion of the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
  3. The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering.
  4. The warrants will expire five years after the completion of the Issuer's initial business combination.
  5. Includes 8,000 warrants underlying the units referred to in footnote 1.